GlassScriptPhysician profile
Kate A Tripp
NPI 1073949236
$1,094.38
in general payments reported to CMS, 2019-2025
18 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $72.20 · 2022: $468 · 2023: $303 · 2024: $135 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $167.90 | 2021-2024 | |
| Endo Pharmaceuticals INC. | $130.07 | 2021-2023 | Aveed, Xiaflex, Edex |
| Axonics, INC. | $125.48 | 2022 | |
| 180 Medical, INC. | $116.82 | 2022-2023 | Gentlecath, Cure Catheter |
| Novo Nordisk INC | $116.44 | 2025 | Wegovy |
| Teleflex LLC | $85.91 | 2021-2024 | Urolift |
| Procept Biorobotics Corporation | $81.73 | 2022 | |
| Astellas Pharma US INC | $65.00 | 2022 | |
| Medtronic, INC. | $60.86 | 2023-2024 | Interstim |
| Rochester Medical Corporation | $23.94 | 2022 | |
| Progenics Pharmaceuticals, INC. | $22.03 | 2023 | Pylarify |
| Tolmar Pharmaceuticals, INC. | $19.60 | 2022 | |
| Glaxosmithkline, LLC. | $16.58 | 2023 | Shingrix |
| Ferring Pharmaceuticals INC. | $16.35 | 2024 | Adstiladrin |
| Boston Scientific Corporation | $15.07 | 2023 | Ams 700 Cxr Rte Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.10 | 2022 | |
| Coloplast Corp | $13.34 | 2021 | |
| Ambu INC. | $3.16 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kate Tripp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.